Health Care Delivery

Experts also explained how hormone therapy can benefit women managing chronic conditions such as diabetes and hypertension on top of their menopause.

Researchers will present new findings on how menopause affects cardiovascular, brain, metabolic, and digestive health.

Thorough eye exams in patients who have myasthenia gravis can detect concurrent autoimmune retinopathy and its complications.

Higher body size and metabolic factors are linked to worse psoriasis and lower biologic treatment success.

Telehealth abortion requests doubled after the Dobbs decision, especially for those far from clinics or seeking care before 6 weeks of pregnancy.

Combination therapy with enfortumab vedotin and pembrolizumab significantly reduces progression and mortality risk of muscle invasive bladder cancer in first-line treatment.

Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies for colorectal cancer.

Patients successfully self-administer rozanolixizumab for generalized myasthenia gravis (gmG), preferring manual push delivery over infusion pumps in a phase 3 trial.

Education on birth control and its potential adverse effects is vital to women choosing the type that best suits them.

Remote monitoring and algorithm-based tools help pharmacists balance complex workloads in value-based care, says Lindsey Valenzuela, PharmD.

Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.

Women who received the mRNA COVID-19 vaccine in their first trimester did not have an increased risk of their child having a major congenital malformation.

A new report shows Vermont, Utah, and Minnesota lead, while Louisiana, Mississippi, and Kentucky lag in Medicare performance.

Patients beginning their cancer journeys should advocate for themselves and use support groups to help navigate survivorship challenges.

Measures need to be taken to elevate engagement both from employees and the general public as public confidence in the US health care system declines.

Adults with diabetes were 24% less likely to visit an emergency department in 2021 than in 2019.

ACOs serving patients with complex needs are on the rise, but policy changes are needed to support providers treating special populations.

Lindsey Valenzuela, PharmD, explains how value-based models empower a single pharmacist to manage multiple layers of these disease states.

CVS Pharmacy acquires stores and prescription files from over 600 Rite Aid and Bartell Drugs pharmacies.

The LINKER-SMM1 trial shows promising results for linvoseltamab in treating high-risk smoldering multiple myeloma with a favorable safety profile, notes Paula Rodríguez-Otero, MD, PhD.

Experts discussed safe and effective management strategies for patients with hidradenitis suppurativa at the 2025 Skin of Color Update.

The number of Black, Hispanic, and Latino students admitted into medical schools fell as rates increased for White and Asian students.

Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD, focus on the best and most effective methods of engaging patients who have myasthenia gravis throughout their journey.

Eliot F. Battle, MD, discusses how to effectively and successfully treat skin of color.

The new indication allows doctors to use upadacitinib before tumor necrosis factor–blocking agents when those treatments are clinically inadvisable.

Opioids were more likely to be prescribed to Medicare beneficiaries living with HIV, which led to opioid use disorder (OUD).

Despite systemic challenges, oncology practices use value-based care, community partnerships, and clinical trials to improve patient access and outcomes, says Brian Mulherin, MD.

WHO's latest report shows alarming trends in antimicrobial resistance, highlighting urgent global challenges and the need to improve surveillance and treatment.

Lindsey Valenzuela, PharmD, explains how pharmacists can prevent drug interactions and improve coordination for women with arrhythmia and chronic disease.

Lindsey Valenzuela, PharmD, explains how cost, coverage gaps, and tech literacy hinder women’s access to early arrhythmia detection tools.